Literature DB >> 12478544

Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.

Andreas Dietz1, Bernhard Vanselow, Volker Rudat, Christian Conradt, Hagen Weidauer, Friedrich Kallinowski, Ralph Dollner.   

Abstract

BACKGROUND: Previous studies have shown that radiation of hypoxic tumors can result in reoxygenation phenomenon. The relevance of this phenomenon for prognosis is unclear. This study analyzes whether the presence of hypoxia, or the extent to which reoxygenation occurs during the initial phase of primary chemoradiation or radiotherapy, can predict the clinical outcome in advanced tumors of the head and neck.
METHODS: The distribution of oxygen partial pressures was determined using pO(2) histography (Kimoc 6650, Sigma pO(2)-Histograph, Eppendorf, Hamburg, Germany). In cervical lymph node metastases of 37 patients with advanced carcinoma of the head and neck (stage IV, UICC), these values were determined before the start of primary chemoradiation or radiotherapy alone (pO(2)x). Thirty-two of 37 patients were reexamined after 1 week of therapy, and measurements were taken again in the same nodes (pO(2)y). The results obtained from these measurements were correlated with both, the initial response to therapy and follow-up results (43 months). RESULTS.: In all patients, pronounced hypoxia (median pO(2), 3.2 mmHg) was found before therapy. In 19 of 32 patients, chemoradiation/radiotherapy induced reoxygenation (deltaO(2) = pO(2)y - pO(2)x), with median deltapO(2) increasing to 6.5 mmHg after 1 week (p =.049). The group of patients with a complete or partial response showed only a slight increase of median deltapO(2) (1 mmHg) compared with a strong reoxygenation effect in the group of patients with no change (mean value of median deltapO(2) = 10.3 mmHg; p =.0062). The group of patients with deltapO(2) values lower than median showed significantly better survival rates compared with the other group (p =.036).
CONCLUSION: These data suggest that reoxygenation under therapy may have prognostic relevance in patients with advanced carcinoma of the head and neck treated by primary chemoradiation or radiation therapy. Remarkably, however, a poor outcome was associated with a higher degree of reoxygenation. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12478544     DOI: 10.1002/hed.10177

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  [Dynamic magnetic resonance tomography (dMRT). It's value in advanced head-neck tumors treated with radiochemotherapy].

Authors:  M Helbig; H-P Schlemmer; M Lumer; M V Knopp; A Dietz
Journal:  HNO       Date:  2003-04-09       Impact factor: 1.284

2.  Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.

Authors:  Nimmi Ramanujam; Mark W Dewhirst; Fangyao Hu; Karthik Vishwanath; Joseph K Salama; Alaattin Erkanli; Bercedis Peterson; James R Oleson; Walter T Lee; David M Brizel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-14       Impact factor: 7.038

3.  Effects of high-dose microbeam irradiation on tumor microvascular function and angiogenesis.

Authors:  Andrew N Fontanella; Mary-Keara Boss; Michael Hadsell; Jian Zhang; Thies Schroeder; Katherine G Berman; Mark W Dewhirst; Sha Chang; Gregory M Palmer
Journal:  Radiat Res       Date:  2015-01-09       Impact factor: 2.841

Review 4.  The clinical importance of assessing tumor hypoxia: relationship of tumor hypoxia to prognosis and therapeutic opportunities.

Authors:  Joseph C Walsh; Artem Lebedev; Edward Aten; Kathleen Madsen; Liane Marciano; Hartmuth C Kolb
Journal:  Antioxid Redox Signal       Date:  2014-05-09       Impact factor: 8.401

5.  Quantitative diffuse reflectance spectroscopy of short-term changes in tumor oxygenation after radiation in a matched model of radiation resistance.

Authors:  Paola Monterroso Diaz; Samir V Jenkins; Kinan Alhallak; Daria Semeniak; Robert J Griffin; Ruud P M Dings; Narasimhan Rajaram
Journal:  Biomed Opt Express       Date:  2018-07-24       Impact factor: 3.732

6.  Global gene expression profiling in three tumor cell lines subjected to experimental cycling and chronic hypoxia.

Authors:  Magdalena Olbryt; Anna Habryka; Sebastian Student; Michał Jarząb; Tomasz Tyszkiewicz; Katarzyna Marta Lisowska
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

7.  Optical imaging of radiation-induced metabolic changes in radiation-sensitive and resistant cancer cells.

Authors:  Kinan Alhallak; Samir V Jenkins; David E Lee; Nicholas P Greene; Kyle P Quinn; Robert J Griffin; Ruud P M Dings; Narasimhan Rajaram
Journal:  J Biomed Opt       Date:  2017-06-01       Impact factor: 3.170

8.  Induction of plasminogen activator inhibitor type-1 (PAI-1) by hypoxia and irradiation in human head and neck carcinoma cell lines.

Authors:  Daniela Schilling; Christine Bayer; Anneke Geurts-Moespot; Fred C G J Sweep; Martin Pruschy; Karin Mengele; Lisa D Sprague; Michael Molls
Journal:  BMC Cancer       Date:  2007-07-30       Impact factor: 4.430

Review 9.  Optical Imaging Approaches to Investigating Radiation Resistance.

Authors:  Sina Dadgar; Narasimhan Rajaram
Journal:  Front Oncol       Date:  2019-11-05       Impact factor: 6.244

10.  Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy.

Authors:  Mary-Keara Boss; Remy Watts; Lauren G Harrison; Sophie Hopkins; Lyndah Chow; Erin Trageser; Carina Easton; Susan M LaRue; Daniel Regan; Mark W Dewhirst; Steven Dow
Journal:  Int J Mol Sci       Date:  2022-01-13       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.